SCHEMBL21052078

SCHEMBL21052078

CC(C)(S)CC(=O)N/N=C1\CCc2cc(OCCC(C(=O)O)N3C(=O)CCC3=O)cc(F)c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22802058 0.95 NPC1 (0.33) —
SCHEMBL21052022 0.86 MAPT (0.32) —
SCHEMBL21052032 0.83 FFAR4 (0.35) —
SCHEMBL21098745 0.83 FFAR4 (0.35) —
SCHEMBL21052079 0.82 BRD4 (0.33) —
SCHEMBL21098744 0.82 BRD4 (0.33) —
SCHEMBL21052173 0.81 MAPT (0.41) —
SCHEMBL21052171 0.78 NPC1 (0.36) —
SCHEMBL21098674 0.78 NPC1 (0.36) —
SCHEMBL21052172 0.78 NPC1 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11576981-B2 Acyl hydrazone linkers, methods and uses thereof ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2023-02-14 — — US disclosed
US-20200397916-A1 ACYL HYDRAZONE LINKERS, METHODS AND USES THEREOF ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2020-12-24 — — US disclosed
EP-3720842-A1 ACYL HYDRAZONE LINKERS, METHODS AND USES THEREOF Ontario Institute For Cancer Research (CA) 2020-10-14 — — EP disclosed
WO-2019109188-A1 ACYL HYDRAZONE LINKERS, METHODS AND USES THEREOF ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2019-06-13 — — WO disclosed
Send feedback